EUVIMEDEUVIMED entdecken
Crossref

Enhanced CFTR modulator efficacy in ΔF508 CFTR mouse organoids by ablation of RFFL ubiquitin ligase

Daichi Hinata, Ryosuke Fukuda, Hiroshi Ishiguro, Yuka Kamada, Tsukasa Okiyoneda

Biochemical and Biophysical Research Communications · 2024

DOI: 10.1016/j.bbrc.2024.150433 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024. Verfasst von Daichi Hinata und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, School of Biological and Environmental Sciences, Kwansei Gakuin University, Sanda, 669-1330, Hyogo, Japan. Hauptthemen laut MEDLINE: Cystic Fibrosis Transmembrane Conductance Regulator, Organoids, Ubiquitin-Protein Ligases, Cystic Fibrosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Takeda Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The most common CFTR mutant in cystic fibrosis (CF), ΔF508 CFTR, is eliminated by ubiquitination even in the presence of CF drugs, reducing their therapeutic efficacy. RFFL is one of the ubiquitin ligases that remove ΔF508 CFTR from the cell surface despite treatment with the triple combination of CFTR modulators (TEZ/ELX/IVA) used clinically. Although RFFL knockdown has been shown to enhance the efficacy of TEZ/ELX/IVA in cell culture models, its impact in mouse models has not been evaluated. Here, we demonstrate that RFFL ablation significantly improves the effect of TEZ/ELX/IVA, resulting in enhanced function of ΔF508 CFTR in mouse organoids. Since RFFL knockout mice showed no significant abnormalities, our findings support RFFL inhibition as a promising strategy to improve CFtreatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic Fibrosis Transmembrane Conductance RegulatorOrganoidsUbiquitin-Protein LigasesCystic FibrosisMice, KnockoutAnimalsMiceAminophenolsBenzodioxolesQuinolonesBenzofuransQuinolinesDrug CombinationsMice, Inbred C57BLAminopyridinesPyrazolesPyridinesPyrrolidines

Stichwörter der Autor:innen

CFTRCFTR modulatorsCystic fibrosisOrganoidsRFFL

Substanzen

Cystic Fibrosis Transmembrane Conductance RegulatorUbiquitin-Protein LigasesAminophenolsBenzodioxolesQuinolonesBenzofuransQuinolinescystic fibrosis transmembrane conductance regulator delta F508Cftr protein, mouseDrug Combinations

Autor:innen und Institutionen

  • Department of Biomedical Sciences, School of Biological and Environmental Sciences, Kwansei Gakuin University, Sanda, 669-1330, Hyogo, Japan.
  • Department of Human Nutrition, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Department of Biomedical Sciences, School of Biological and Environmental Sciences, Kwansei Gakuin University, Sanda, 669-1330, Hyogo, Japan. Electronic address: t-okiyoneda@kwansei.ac.jp.

Förderung

  • Takeda Science Foundation

Zitieren

APA

Hinata, D., Fukuda, R., Ishiguro, H., Kamada, Y., & Okiyoneda, T. (2024). Enhanced CFTR modulator efficacy in ΔF508 CFTR mouse organoids by ablation of RFFL ubiquitin ligase. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2024.150433

Vancouver

Hinata D, Fukuda R, Ishiguro H, Kamada Y, Okiyoneda T. Enhanced CFTR modulator efficacy in ΔF508 CFTR mouse organoids by ablation of RFFL ubiquitin ligase. Biochemical and Biophysical Research Communications. 2024. doi:10.1016/j.bbrc.2024.150433

BibTeX
@article{Hinata2024,
  author = {Hinata, Daichi and Fukuda, Ryosuke and Ishiguro, Hiroshi and Kamada, Yuka and Okiyoneda, Tsukasa},
  title = {Enhanced CFTR modulator efficacy in ΔF508 CFTR mouse organoids by ablation of RFFL ubiquitin ligase},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2024},
  doi = {10.1016/j.bbrc.2024.150433}
}
Kostenlos starten →